Tag: John Kamp

John Kamp

CHC News

James Potter Named as New CHC Executive Director

James Potter Named as New CHC Executive Director

WASHINGTON, D.C., March 28, 2023 – James (Jim) Potter has been named the new Executive Director for the Coalition of Healthcare Communications (CHC), following the retirement of Jon Bigelow, and its acquisition by the American Association of Advertising Agencies (4A’s) in 2022. The acquisition was made to enable the CHC to expand their capabilities for […]

Read more

CHC News

CHC’s John Kamp Inducted into Medical Advertising Hall of Fame

CHC’s John Kamp Inducted into Medical Advertising Hall of Fame

Feb. 11, 2020 – John Kamp, who served for 16 years as the executive director of the Coalition for Healthcare Communication, last week was inducted into the Medical Advertising Hall of Fame (MAHF) and given the MAHF’s 2020 Service to Industry Award. “John is a wise, shrewd, and articulate defender of the First Amendment right […]

Read more

Washington Focus

Holcombe: ‘Hill Staffers Are Incredibly and Shockingly Important’

Holcombe: ‘Hill Staffers Are Incredibly and Shockingly Important’

Aug. 19, 2019 – As presidential hopefuls discuss the possible merits of “Medicare for All” and other healthcare reforms, discourse in the nation’s capital has deteriorated to the point where “no one talks to each other,” according to Kay Holcombe, who recently retired as senior vice president for science policy at the Biotechnology Innovation Organization. […]

Read more

Legislative

Position on Reporting Reprints and Textbooks Appears to Be Shifting

Position on Reporting Reprints and Textbooks Appears to Be Shifting

Sept. 27, 2018 – Although it was the Obama administration’s position that reprints and textbooks received by physicians were transfers of value that were fully reportable under the Sunshine Act Open Payments regulation, the Trump administration and Congress are taking another look at the matter, according to John Kamp, Washington Counsel, Coalition for Healthcare Communication. […]

Read more

CHC News

Jon Bigelow Is New CHC Executive Director

Jon Bigelow Is New CHC Executive Director

Sept. 17, 2018 – After 16 years with the Coalition for Healthcare Communication, John Kamp will be stepping down as Executive Director and Jon Bigelow has been named his successor. Kamp will continue his association with the Coalition as Washington Counsel. “Jon is exactly the right person at the right time to take the guiding […]

Read more

DTC Advertising

Senate and HHS Make Moves to Advance Mandatory Drug Prices in Consumer Ads

Senate and HHS Make Moves to Advance Mandatory Drug Prices in Consumer Ads

Aug. 24, 2018 – Yesterday was a one-two punch in the Trump administration’s effort to move forward a plan to require that drug manufacturers include drug prices in ads directed toward consumers, as the White House Office of Management and Budget (OMB) reviews a proposed rule from the Department of Health & Human Services (HHS) […]

Read more

CHC News

Jack Angel to Retire from the CHC

Jack Angel to Retire from the CHC

Aug. 2, 2018 – Roughly 27 years after the Coalition for Healthcare Communication was established, Jack Angel – one of the Coalition’s founding members and the current executive director of the Coalition’s Education Foundation – is retiring on Aug. 17. Angel was the Executive Director of the Coalition from its beginning in 1991 to 2004, […]

Read more

Regulatory/FDA

FDA Cracks Down on Deceptive Claims for “Vaginal Rejuvenation” Procedures

FDA Cracks Down on Deceptive Claims for “Vaginal Rejuvenation” Procedures

July 31, 2018 – Stating that the FDA’s “most fundamental obligation” is “providing patients with access to safe and effective medical products to meet their health care needs,” FDA Commissioner Scott Gottlieb, M.D., issued a statement July 30 warning women that the FDA has “serious concerns” about laser and energy-based devices cleared or approved for […]

Read more

Legislative

House Appropriations Bill Does Not Include Authorization of Mandatory Drug Prices in Ads

House Appropriations Bill Does Not Include Authorization of Mandatory Drug Prices in Ads

July 13, 2018 – On the “no news is good news” front, the House Appropriations Committee voted this week on next year’s funding level for the U.S. Department of Health and Human Services (HHS) without taking up an amendment to give HHS and FDA explicit authority to mandate drug list prices in consumer advertising. “What […]

Read more

Regulatory/FDA

FDA Final Guidance Documents on Communication Issues Improve Clarity

FDA Final Guidance Documents on Communication Issues Improve Clarity

June 14, 2018 – Although they may not be perfect, the two final guidance documents issued this week by the FDA do provide more information and examples to help pharma companies navigate how they communicate with payors and how they ensure that their on-label communications are compliant. In a June 12 statement, FDA Commissioner Scott […]

Read more